Ixekizumab
Ixekizumab
Immunoglobulin G4, anti-(human interleukin 17A) (human monoclonal LY2439821 gamma4-chain), disulfide with human monoclonal LY2439821 kappa-chain, dimer
Stoffgruppe
Immunsuppressivum (Interleukin-Inhibitor)
Halbwertszeit
13 Tage